AU5476901A - A method of administering an antitumour compound - Google Patents
A method of administering an antitumour compoundInfo
- Publication number
- AU5476901A AU5476901A AU54769/01A AU5476901A AU5476901A AU 5476901 A AU5476901 A AU 5476901A AU 54769/01 A AU54769/01 A AU 54769/01A AU 5476901 A AU5476901 A AU 5476901A AU 5476901 A AU5476901 A AU 5476901A
- Authority
- AU
- Australia
- Prior art keywords
- administering
- antitumour compound
- antitumour
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0008928.4A GB0008928D0 (en) | 2000-04-11 | 2000-04-11 | A method of administering an antitumour compound |
GB0008928 | 2000-04-11 | ||
PCT/EP2001/003765 WO2001076597A2 (en) | 2000-04-11 | 2001-04-03 | A method of administering an antitumour compound using a polymer-camptothecin conjugate |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5476901A true AU5476901A (en) | 2001-10-23 |
Family
ID=9889704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU54769/01A Abandoned AU5476901A (en) | 2000-04-11 | 2001-04-03 | A method of administering an antitumour compound |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU5476901A (en) |
GB (1) | GB0008928D0 (en) |
WO (1) | WO2001076597A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5170741B2 (en) | 2004-04-27 | 2013-03-27 | ウェルスタット バイオロジクス コーポレイション | Treatment of cancer using viruses and camptothecins |
JP5190958B2 (en) | 2005-07-14 | 2013-04-24 | ウェルスタット バイオロジクス コーポレイション | Treatment of cancer using viruses, fluoropyrimidine and camptothecin |
JP6877049B2 (en) | 2015-09-25 | 2021-05-26 | ゼットワイ セラピューティクス インク.Zy Therapeutics Inc. | Drug formulation based on granules containing polysaccharide-vitamin conjugate |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9320781D0 (en) * | 1993-10-08 | 1993-12-01 | Erba Carlo Spa | Polymer-bound camptothecin derivatives |
GB9721069D0 (en) * | 1997-10-03 | 1997-12-03 | Pharmacia & Upjohn Spa | Polymeric derivatives of camptothecin |
GB9721070D0 (en) * | 1997-10-03 | 1997-12-03 | Pharmacia & Upjohn Spa | Bioactive derivatives of camptothecin |
GB9915180D0 (en) * | 1999-06-29 | 1999-09-01 | Pharmacia & Upjohn Spa | Antitumour compound |
-
2000
- 2000-04-11 GB GBGB0008928.4A patent/GB0008928D0/en not_active Ceased
-
2001
- 2001-04-03 AU AU54769/01A patent/AU5476901A/en not_active Abandoned
- 2001-04-03 WO PCT/EP2001/003765 patent/WO2001076597A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
GB0008928D0 (en) | 2000-05-31 |
WO2001076597A3 (en) | 2002-05-16 |
WO2001076597A2 (en) | 2001-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AUPQ687600A0 (en) | A method of detection | |
AU2001266345A1 (en) | Five-membered-ring compound | |
AU2002361357A1 (en) | Method for monosulphonylation of an aminobenzofuran compound | |
AUPR409401A0 (en) | Analgesic compound | |
AU2002249197A1 (en) | 1g(a)-amino-n-hydroxy-acetamide derivatives | |
AU5476901A (en) | A method of administering an antitumour compound | |
AUPQ835400A0 (en) | A method of mining | |
AUPQ575300A0 (en) | New compound | |
AU3668100A (en) | A compound magnet | |
AU2002308986A1 (en) | Process for preparation of a quinolinecarbaldehyde | |
AU4880401A (en) | Process for producing amide compound | |
AUPQ781100A0 (en) | A method of detection | |
AU2001214172A1 (en) | Macrocyclic compound | |
AUPR234400A0 (en) | New compound | |
AU2001236266A1 (en) | Use of a compound for preparing a drug | |
AU2002224034A1 (en) | Method of searching for novel lead compound | |
AUPR663501A0 (en) | A method of administering a gm-csf antagonist | |
AUPR120400A0 (en) | New compound | |
AUPR726201A0 (en) | New use of a cyclic compound | |
AUPR738001A0 (en) | Compound for medicinal purposes | |
AUPR870401A0 (en) | A method of detection - II | |
AUPR542301A0 (en) | A method of screening-ii | |
AUPR385501A0 (en) | A method of detection - II | |
AU1871101A (en) | Cyclic compound | |
AUPQ618600A0 (en) | A method of enabling a dual purpose parser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |